Findings show noninferior outcomes at three months versus cognitive behavioral therapy

Findings based on a systematic literature review of studies reporting the use of ketamine, esketamine for treatment-resistant depression

However, survivors had more problems with mobility, pain or discomfort, anxiety or depression at one year than controls

Adults with disabilities more often report that the pandemic makes it harder for them to access care, medication

Benefits include cognitive and functional outcomes even for severely affected patients